NO_LONGER_AVAILABLENot Applicable

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

United States

Plain-language summary

This study uses fecal microbiota transplant (FMT) to correct gut microbiome dysbiosis prior to and during standard-of-care neuroblastoma treatment

Who can participate

Age range5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * willingness of parent/guardian to sign ICF * diagnosis of neuroblastoma * dysbiosis of the gut microbiome Exclusion Criteria: * parent/guardian unwilling to sign ICF * dysbiosis does not show a bifidobaceteria-bacteroides gap * severely abnormal screening lab values

Trial details

NCT IDNCT07223606

SponsorProgenaBiome

Sponsor typeOTHER

Study typeEXPANDED_ACCESS

View on ClinicalTrials.gov More Neuroblastoma trials